| Being listed as one of the ten pillar industries by government, biological medicine has played amore and more important role in the development of economy of China. And it has become the focusof competition of countries in the world. Biological pharmaceutical enterprises in China are on theirway from imitating to creating; on the other hand, however, they are confronting with numerousproblems. And core competitiveness promotion is obviously the key to a success in the competitivemarket.This thesis is based on literature search of core competitiveness and related comprehensivecompetition. In this thesis, the author takes the features of biological pharmaceutical enterprises intoconsideration, founds a core competitiveness evaluation index system, and makes reliability analysisvalidity analysis of it. Furthermore, a final index system takes form. At the same time, this thesismakes use of vague mathematics, AHP (analytic hierarchy process), and fuzzy comprehensiveevaluation to provide the basis of quantitative study of core competitiveness evaluation of biologicalpharmaceutical enterprises in China.Case analysis of Henan Hua Lan pharmaceutical company comes next, and how the indeximportance is reflected in this company is also studied. Besides, weighted value is fixed by AHP,evaluation sets and membership functions are also fixed. Thus, final fuzzy comprehensive evaluationis finished and the result comes out. This study provides a practical example for core competitivenessevaluation of biological pharmaceutical enterprises. |
PDF Full Text Request